Home/Academy/Journal Finder/Annals of Oncology
Annals of Oncology
Elsevier, on behalf of the European Society for Medical Oncology (ESMO)
Clinical oncology and clinically oriented cancer research, including phase III randomised trials, translational studies and ESMO clinical practice guidelines.
Overview
Annals of Oncology is published by Elsevier, on behalf of the European Society for Medical Oncology (ESMO). Clinical oncology and clinically oriented cancer research, including phase III randomised trials, translational studies and ESMO clinical practice guidelines.
Key information
Official journal of ESMO (and of the Japanese Society of Medical Oncology); previously published by Kluwer, Springer and Oxford University Press before Elsevier. Word limits for original articles conflict across secondary sources (3,500 vs 4,500 words), so none are recorded until the current Elsevier guide for authors can be read directly.
Aims & scope
- Clinical oncology and clinically oriented cancer research, including phase III randomised trials, translational studies and ESMO clinical practice guidelines.
No per-article-type breakdown verified yet for this journal.
General formatting rules that apply across article types. Specific word, abstract, reference and figure limits vary by article type — see the Article types tab for those.
General requirements
Manuscript template
Not yet verified
Information on the submission process and the ethics and publication standards Annals of Oncology applies.
Submission process
Ethics & publication standards
Not yet verified
Author guidelines
Read the complete and latest author instructions on the journal website.
View author guidelinesData availability
Not yet verified
Document and declaration checklists (cover letter, disclosures, registration numbers, etc.) follow ICMJE recommendations generally — we have not independently itemized Annals of Oncology's exact required-documents list, so check the live author guidelines before submitting.
Sample articles
Recent, relevant articles published in Annals of Oncology. These examples help you understand the journal's scope, style and expected quality — we only list one once its title, DOI, year and article type are verified against the publisher's own page.
Filter examples
Article type
Learn from examples
- Review the structure, formatting and presentation style the journal actually publishes.
- Use examples together with the Article types and Manuscript specs tabs, not as a substitute for the journal's own guidelines.
- Check article-type-specific requirements before drafting.
Title, authors, article type, publication date and DOI confirmed against each article's PubMed record (retrieved 11 Nov 2026).
General stages a manuscript moves through at most peer-reviewed journals — this sequence is standard academic-publishing practice, not a claim we've verified against Annals of Oncology's own workflow. Durations below are shown only where the publisher has actually disclosed them.
Manuscript submitted via the journal's submission system.
Administrative and scope check by the editorial office.
Editor decides whether to send the manuscript for peer review.
External review by expert referees.
Accept, minor/major revision, or reject.
Author submits a revised manuscript, if requested.
Editor confirms acceptance.
Online-first, then the print/issue assignment if applicable.
Key timeline statistics
Factors that may affect timeline
- Type and complexity of the study
- Speed of author response to reviewer comments
- Number of revision rounds
- Availability of expert reviewers
- Editorial and production workload
- Compliance with the journal's own guidelines
General tips for faster processing
- Confirm the manuscript fits the journal's scope before submitting
- Follow the author guidelines and formatting requirements closely
- Respond to reviewer comments completely and promptly
- Submit all required documents and declarations at the time of submission
The stage sequence and general tips above reflect typical academic-publishing practice, not data we've verified against Annals of Oncology specifically. Any duration we haven't independently confirmed from the publisher reads as "not yet verified" rather than an estimate.
Indexing and abstracting services
MEDLINE status confirmed from the journal's PubMed records (NLM abbreviation Ann Oncol). Scopus and Web of Science not independently confirmed here.
Citation metrics
Not yet verified
Requires a licensed Scopus/JCR/SCImago lookup we have not run for this title.
Not yet verified
Requires a licensed Scopus/JCR/SCImago lookup we have not run for this title.
Not yet verified
Requires a licensed Scopus/JCR/SCImago lookup we have not run for this title.
Not yet verified
Requires a licensed Scopus/JCR/SCImago lookup we have not run for this title.
Journal quartile
Scopus and Web of Science classify journals into their own category sets — we show the one subject category we've confirmed rather than listing categories we haven't checked.
Additional metrics
CiteScore details (2024)
Metric notes
- CiteScore here is an aggregate pulled from a third-party metrics site, not fetched from Scopus directly — confirm there before citing it.
- Impact Factor, SJR, SNIP, quartile, h-index and citation counts require a licensed Scopus/JCR/SCImago lookup we have not independently run for this title.
- Indexing status reflects only what we've checked against the publisher or the NLM Catalog — an item marked not-yet-verified may still index this journal.
Publication charges and author-facing fees. Elsevier, on behalf of the European Society for Medical Oncology (ESMO) has not published a per-route APC schedule we could independently verify for Annals of Oncology — every amount below is honestly unknown rather than estimated, not a $0 fee.
Publication charges (APC)
Additional charges
Check current fees
Publication-charge and open-access policy pages change independently of this profile.
Visit journal websiteLicence & copyright
- Publishing agreements and licence terms are set by the publisher and vary by publishing route.
- We have not independently verified Annals of Oncology's specific licence (e.g. a named Creative Commons variant) — confirm on the journal website before relying on it.
Based on what Elsevier, on behalf of the European Society for Medical Oncology (ESMO) has publicly stated for Annals of Oncology as of our last check — verify current fees and policy on the journal website before budgeting or submitting.
- Best fit for manuscripts in clinical oncology and clinically oriented cancer research, including phase iii randomised trials, translational studies and esmo clinical practice guidelines. — not a narrow subspecialty-only readership.
These notes are Pubrica's own read of the journal's published guidelines, not a claim about editorial preference or acceptance likelihood.
Verified against Elsevier's journal pages (open access information, guide for authors listing), ESMO's editorial board pages and the journal's PubMed records.